癌症临床试验中使用患者报告的不良事件通用术语标准（PRO-CTCAE）的方法学标准。 - Suppr

Suppr

超能文献

Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials.

作者信息

Basch Ethan, Thanarajasingam Gita, Dueck Amylou C

机构信息

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

出版信息

Clin Trials. 2022 Jun;19(3):274-276. doi: 10.1177/17407745221093922. Epub 2022 May 15.

DOI:10.1177/17407745221093922

PMID:35575014

Abstract

摘要

相似文献

Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials.癌症临床试验中使用患者报告的不良事件通用术语标准（PRO-CTCAE）的方法学标准。

Clin Trials. 2022 Jun;19(3):274-276. doi: 10.1177/17407745221093922. Epub 2022 May 15.

Danish Translation and Linguistic Validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).美国国立癌症研究所不良事件通用术语标准患者报告结局版（PRO-CTCAE）的丹麦语翻译及语言验证

J Pain Symptom Manage. 2016 Aug;52(2):292-7. doi: 10.1016/j.jpainsymman.2016.02.008. Epub 2016 Apr 15.

Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).使用美国国家癌症研究所的患者报告结局版常见不良事件术语标准（PRO-CTCAE），对癌症临床研究中的症状性不良事件进行患者自由文本报告。

J Am Med Inform Assoc. 2019 Apr 1;26(4):276-285. doi: 10.1093/jamia/ocy169.

Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).癌症临床试验中的患者报告结局：使用美国国立癌症研究所不良事件通用术语标准的患者报告结局版本（PRO-CTCAE）测量症状性不良事件。

Am Soc Clin Oncol Educ Book. 2016;35:67-73. doi: 10.1200/EDBK_159514.

Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).国家癌症研究所患者报告结局版通用不良事件术语标准（PRO-CTCAE）的综合分级算法。

Clin Trials. 2021 Feb;18(1):104-114. doi: 10.1177/1740774520975120. Epub 2020 Dec 1.

Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a diverse cancer sample.不同癌症样本中患者报告的不良事件通用术语标准（PRO-CTCAE）的项目和汇总分数的统计特性。

Clin Trials. 2025 Apr;22(2):161-169. doi: 10.1177/17407745241286065. Epub 2024 Oct 23.

Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.在肿瘤学试验的不良事件报告中引出儿童的声音：不良事件通用术语标准儿科患者报告结局版本的认知访谈结果

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26261. Epub 2016 Sep 21.

Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.使用完整的患者报告结局版常见不良事件术语标准（PRO-CTCAE）项目库的可行性评估。

Oncologist. 2019 Apr;24(4):e146-e148. doi: 10.1634/theoncologist.2018-0332. Epub 2019 Feb 6.

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).美国国家癌症研究所患者报告结局版通用不良事件术语标准（PRO-CTCAE）的有效性和可靠性。

JAMA Oncol. 2015 Nov;1(8):1051-9. doi: 10.1001/jamaoncol.2015.2639.

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).国家癌症研究所患者报告结局版通用不良事件术语标准（PRO-CTCAE）的制定。

J Natl Cancer Inst. 2014 Sep 29;106(9). doi: 10.1093/jnci/dju244. Print 2014 Sep.

引用本文的文献

Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in Fusion-Positive NSCLC.LIBRETTO-431研究的患者报告结局：一线使用塞尔帕替尼与帕博利珠单抗化疗治疗融合阳性非小细胞肺癌的对比

JTO Clin Res Rep. 2025 Feb 19;6(7):100814. doi: 10.1016/j.jtocrr.2025.100814. eCollection 2025 Jul.

Adherence to daily electronic symptom screening in pediatric cancer: associations with time, location and pain.儿科癌症患者每日电子症状筛查的依从性：与时间、地点和疼痛的关联

Qual Life Res. 2025 Jun 10. doi: 10.1007/s11136-025-04002-0.

Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients.晚期转移性膀胱癌患者中患者与临床医生报告的症状一致性

Cancer Med. 2025 Apr;14(8):e70896. doi: 10.1002/cam4.70896.

Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials.多发性骨髓瘤临床试验中患者报告结局的使用与报告指南。

Cancers (Basel). 2023 Dec 8;15(24):5764. doi: 10.3390/cancers15245764.

A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.定制的 I 期特定患者报告结局（PRO）调查，以捕捉症状性不良事件的患者体验。

Br J Cancer. 2023 Sep;129(4):612-619. doi: 10.1038/s41416-023-02307-w. Epub 2023 Jul 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验